Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-047638
Filing Date
2024-11-25
Accepted
2024-11-25 17:06:10
Documents
1
Period of Report
2024-11-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4437
  Complete submission text file 0001493152-24-047638.txt   6096
Mailing Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131
Business Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131 786-396-6723
Telomir Pharmaceuticals, Inc. (Issuer) CIK: 0001971532 (see all company filings)

IRS No.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MIRA PHARMACEUTICALS, INC. 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606-2173
Business Address C/O MIRA PHARMACEUTICALS, INC. 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606-2173 (737) 289-0835
Bay Shore Trust (Reporting) CIK: 0001986593 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41952 | Film No.: 241496902